GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (STU:1FX) » Definitions » EV-to-FCF

Ananda Pharma (STU:1FX) EV-to-FCF : (As of Apr. 07, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Ananda Pharma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ananda Pharma's Enterprise Value is €26.47 Mil. Ananda Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2023 was €0.00 Mil. Therefore, Ananda Pharma's EV-to-FCF for today is .

The historical rank and industry rank for Ananda Pharma's EV-to-FCF or its related term are showing as below:

STU:1FX's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.12
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-07), Ananda Pharma's stock price is €0.0035. Ananda Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2023 was €-0.002. Therefore, Ananda Pharma's PE Ratio (TTM) for today is At Loss.


Ananda Pharma EV-to-FCF Historical Data

The historical data trend for Ananda Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma EV-to-FCF Chart

Ananda Pharma Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
EV-to-FCF
- -1.90 - - -20.82

Ananda Pharma Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - -20.82 -

Competitive Comparison of Ananda Pharma's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Ananda Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ananda Pharma's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ananda Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Ananda Pharma's EV-to-FCF falls into.


;
;

Ananda Pharma EV-to-FCF Calculation

Ananda Pharma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=26.468/0
=

Ananda Pharma's current Enterprise Value is €26.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ananda Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2023 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ananda Pharma  (STU:1FX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Ananda Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0035/-0.002
=At Loss

Ananda Pharma's share price for today is €0.0035.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ananda Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2023 was €-0.002.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Ananda Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Pharma Business Description

Traded in Other Exchanges
N/A
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Pharma PLC is focused on the development of cannabinoid therapies for the treatment of a range of complex conditions. The company is developing NHS-approved and MHRA-licensed cannabinoid medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with CIPN & endometriosis) and HFpEF heart failure.

Ananda Pharma Headlines

No Headlines